Leukocyte telomere length in HIV-infected and HIV-Exposed uninfected children: Shorter telomeres with uncontrolled HIV viremia

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Côté, Hélène C F ^a,b   Soudeyns, Hugo ^c,d   Thorne, Anona ^e   Alimenti, Ariane ^a,f   Lamarre, Valérie ^c,d   Maan, Evelyn J ^f   Sattha, Beheroze ^a   Singer, Joel ^a,e   Lapointe, Normand ^c,d   Money, Deborah M ^a,b,f   Forbes, John ^a,f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Women's Health Research Institute   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e Canadian HIV Trials Network   (Canada)

^f CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; DIDANOSINE; EMTRICITABINE; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CELL SIZE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; LEUKOCYTE TELOMERE LENGTH; MAJOR CLINICAL STUDY; MALE; PERINATAL DRUG EXPOSURE; PRESCHOOL CHILD; SCHOOL CHILD; SEX DIFFERENCE; TELOMERE SHORTENING; VIREMIA; VIRUS LOAD;

ADOLESCENT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; FEMALE; HIV INFECTIONS; HUMANS; INFANT; LEUKOCYTES; LINEAR MODELS; MALE; PREGNANCY; REVERSE TRANSCRIPTASE INHIBITORS; TELOMERASE; TELOMERE; VIREMIA; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84864015675     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039266     Document Type: Article

References (50)

1. Gray GE, McIntyre JA, (2007) HIV and pregnancy. Bmj 334: 950-953.
2. World Health Organization (2010) Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva, Switzerland: World Health Organization.
3. AIDSinfo website (2011) Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Available:http://aidsinfo.nih.gov/contentfiles/PerinatalGL.pdf. Accessed 2011 July 13.
4. Forbes JC, Alimenti AM, Singer J, Brophy JC, Bitnun A, et al. (2012) A national review of vertical HIV transmission. AIDS 26: 757-763.
5. World Health Organization website. Available:http://www.who.int/hiv/topics/paediatric/en/index.html. Published 2010. Accessed 2011 Jul 13.
6. Chappuy H, Treluyer JM, Jullien V, Dimet J, Rey E, et al. (2004) Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother 48: 4332-4336.
7. Zhu H, Belcher M, van der Harst P, (2011) Healthy aging and disease: role for telomere biology? Clin Sci (Lond) 120: 427-440.
8. Majerska J, Sykorova E, Fajkus J, (2011) Non-telomeric activities of telomerase. Mol Biosyst 7: 1013-1023.
9. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW, (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179.
10. Collins K, Mitchell JR, (2002) Telomerase in the human organism. Oncogene 21: 564-579.
11. Effros RB, (2011) Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress. Exp Gerontol 46: 135-140.
12. Bestilny LJ, Gill MJ, Mody CH, Riabowol KT, (2000) Accelerated replicative senescence of the peripheral immune system induced by HIV infection. Aids 14: 771-780.
13. Deeks SG, (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62: 141-155.
14. Gillis AJ, Schuller AP, Skordalakes E, (2008) Structure of the Tribolium castaneum telomerase catalytic subunit TERT. Nature 455: 633-637.
15. Peng Y, Mian IS, Lue NF, (2001) Analysis of telomerase processivity: mechanistic similarity to HIV-1 reverse transcriptase and role in telomere maintenance. Mol Cell 7: 1201-1211.
16. Yamaguchi T, Takayama Y, Saito M, Ishikawa F, Saneyoshi M, (2001) Telomerase-inhibitory effects of the triphosphate derivatives of some biologically active nucleosides. Nucleic Acids Res.
17. Hukazelie KC, Wong J, (2011) In vitro and in vivo inhibition studies of human telomerase by HIV reverse transcriptase. 20th Annual Canadian Conference on HIV/AIDS Research. Toronto, Ontario, Canada: Can J Infect Dis Med Microbiol.
18. Strahl C, Blackburn EH, (1996) Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 16: 53-65.
19. Brown T, Sigurdson E, Rogatko A, Broccoli D, (2003) Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line. Ann Surg Oncol 10: 910-915.
20. Liu X, Takahashi H, Harada Y, Ogawara T, Ogimura Y, et al. (2007) 3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells. Nucleic Acids Res 35: 7140-7149.
21. Strahl C, Blackburn EH, (1994) The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena. Nucleic Acids Res 22: 893-900.
22. Olivero OA, Fernandez JJ, Antiochos BB, Wagner JL, St Claire ME, et al. (2002) Transplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in Erythrocebus patas monkeys. J Acquir Immune Defic Syndr 29: 323-329.
23. Bazarbachi A, Plumelle Y, Carlos Ramos J, Tortevoye P, Otrock Z, et al. (2010) Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol 28: 4177-4183.
24. Datta A, Bellon M, Sinha-Datta U, Bazarbachi A, Lepelletier Y, et al. (2006) Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood 108: 1021-1029.
25. De Meyer T, Rietzschel ER, De Buyzere ML, Van Criekinge W, Bekaert S, (2011) Telomere length and cardiovascular aging: the means to the ends? Ageing Res Rev 10: 297-303.
26. Sanders JL, Fitzpatrick AL, Boudreau RM, Arnold AM, Aviv A, et al. (2011) Leukocyte Telomere Length Is Associated With Noninvasively Measured Age-Related Disease: The Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci.
27. Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, et al. (2010) Telomere length and risk of incident cancer and cancer mortality. JAMA 304: 69-75.
28. Cawthon RM, (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30: e47.
29. Gil ME, Coetzer TL, (2004) Real-time quantitative PCR of telomere length. Mol Biotechnol 27: 169-172.
30. Oliveira LSB, Hukezalie K, Maan E, Gadawski I, Vulto I, et al. (2010) Telomere length measurement in fresh and frozen cord blood and placenta by quantitative PCR: comparison with other methods. Can J Inf Dis Med Microbiol 21: 32B.
31. Frenck RW Jr, Blackburn EH, Shannon KM, (1998) The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci U S A 95: 5607-5610.
32. Zeichner SL, Palumbo P, Feng Y, Xiao X, Gee D, et al. (1999) Rapid telomere shortening in children. Blood 93: 2824-2830.
33. Mayer S, Bruderlein S, Perner S, Waibel I, Holdenried A, et al. (2006) Sex-specific telomere length profiles and age-dependent erosion dynamics of individual chromosome arms in humans. Cytogenet Genome Res 112: 194-201.
34. Moller P, Mayer S, Mattfeldt T, Muller K, Wiegand P, et al. (2009) Sex-related differences in length and erosion dynamics of human telomeres favor females. Aging (Albany NY) 1: 733-739.
35. Zhu H, Wang X, Gutin B, Davis CL, Keeton D, et al. (2011) Leukocyte telomere length in healthy Caucasian and African-American adolescents: relationships with race, sex, adiposity, adipokines, and physical activity. J Pediatr 158: 215-220.
36. Okuda K, Bardeguez A, Gardner JP, Rodriguez P, Ganesh V, et al. (2002) Telomere length in the newborn. Pediatr Res 52: 377-381.
37. Aviv A, (2002) Telomeres, sex, reactive oxygen species, and human cardiovascular aging. J Mol Med 80: 689-695.
38. De Meyer T, Rietzschel ER, De Buyzere ML, De Bacquer D, Van Criekinge W, et al. (2007) Paternal age at birth is an important determinant of offspring telomere length. Hum Mol Genet 16: 3097-3102.
39. Kimura M, Cherkas LF, Kato BS, Demissie S, Hjelmborg JB, et al. (2008) Offspring's leukocyte telomere length, paternal age, and telomere elongation in sperm. PLoS Genet 4: e37.
40. Nordfjall K, Svenson U, Norrback KF, Adolfsson R, Roos G, (2010) Large-scale parent-child comparison confirms a strong paternal influence on telomere length. Eur J Hum Genet 18: 385-389.
41. Rickabaugh TM, Kilpatrick RD, Hultin LE, Hultin PM, Hausner MA, et al. (2011) The dual impact of HIV-1 infection and aging on naive CD4 T-cells: additive and distinct patterns of impairment. PLoS One 6: e16459.
42. Lin J, Epel E, Cheon J, Kroenke C, Sinclair E, et al. (2010) Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J Immunol Methods 352: 71-80.
43. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
44. Hunt PW, (2012) HIV and Inflammation: Mechanisms and Consequences. Curr HIV/AIDS Rep.
45. El-Sadr WM, Grund B, Neuhaus J, Babiker A, Cohen CJ, et al. (2008) Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med 149: 289-299.
46. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, et al. (2008) Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 5: e203.
47. Trudeau MA, Wong JM, (2010) Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies. Curr Pharmacogenomics Person Med 8: 7-24.
48. van de Berg PJ, Griffiths SJ, Yong SL, Macaulay R, Bemelman FJ, et al. (2010) Cytomegalovirus infection reduces telomere length of the circulating T cell pool. J Immunol 184: 3417-3423.
49. Pawelec G, Akbar A, Caruso C, Effros R, Grubeck-Loebenstein B, et al. (2004) Is immunosenescence infectious? Trends Immunol 25: 406-410.
50. Dock JN, Effros RB, (2011) Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence. Aging Dis 2: 382-397.